Medistim ASA (FRA:MD1)
Germany flag Germany · Delayed Price · Currency is EUR
19.50
+0.40 (2.09%)
Last updated: Sep 30, 2025, 8:05 AM CET

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of EUR 355.52 million. The enterprise value is 349.18 million.

Market Cap355.52M
Enterprise Value 349.18M

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date Oct 24, 2025
Ex-Dividend Date May 9, 2025

Share Statistics

Current Share Class 18.27M
Shares Outstanding n/a
Shares Change (YoY) -0.07%
Shares Change (QoQ) -0.33%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 12.61M

Valuation Ratios

The trailing PE ratio is 32.21 and the forward PE ratio is 28.39.

PE Ratio 32.21
Forward PE 28.39
PS Ratio 6.72
PB Ratio 11.00
P/TBV Ratio 13.32
P/FCF Ratio 28.91
P/OCF Ratio 27.75
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.14, with an EV/FCF ratio of 28.39.

EV / Earnings 31.63
EV / Sales 6.51
EV / EBITDA 21.14
EV / EBIT 23.92
EV / FCF 28.39

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.06.

Current Ratio 3.14
Quick Ratio 1.73
Debt / Equity 0.06
Debt / EBITDA 0.11
Debt / FCF 0.15
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 34.19% and return on invested capital (ROIC) is 26.75%.

Return on Equity (ROE) 34.19%
Return on Assets (ROA) 21.13%
Return on Invested Capital (ROIC) 26.75%
Return on Capital Employed (ROCE) 41.59%
Revenue Per Employee 343,289
Profits Per Employee 71,677
Employee Count154
Asset Turnover 1.24
Inventory Turnover 0.71

Taxes

In the past 12 months, Medistim ASA has paid 3.44 million in taxes.

Income Tax 3.44M
Effective Tax Rate 23.75%

Stock Price Statistics

The stock price has increased by +31.76% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +31.76%
50-Day Moving Average 20.06
200-Day Moving Average 16.32
Relative Strength Index (RSI) 42.53
Average Volume (20 Days) 2

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of EUR 52.87 million and earned 11.04 million in profits. Earnings per share was 0.60.

Revenue52.87M
Gross Profit 42.69M
Operating Income 14.40M
Pretax Income 14.48M
Net Income 11.04M
EBITDA 15.55M
EBIT 14.40M
Earnings Per Share (EPS) 0.60
Full Income Statement

Balance Sheet

The company has 8.11 million in cash and 1.85 million in debt, giving a net cash position of 6.26 million.

Cash & Cash Equivalents 8.11M
Total Debt 1.85M
Net Cash 6.26M
Net Cash Per Share n/a
Equity (Book Value) 32.31M
Book Value Per Share 1.77
Working Capital 22.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.81 million and capital expenditures -510,751, giving a free cash flow of 12.30 million.

Operating Cash Flow 12.81M
Capital Expenditures -510,751
Free Cash Flow 12.30M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 80.74%, with operating and profit margins of 27.23% and 20.88%.

Gross Margin 80.74%
Operating Margin 27.23%
Pretax Margin 27.38%
Profit Margin 20.88%
EBITDA Margin 29.42%
EBIT Margin 27.23%
FCF Margin 23.26%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 2.60%.

Dividend Per Share 0.51
Dividend Yield 2.60%
Dividend Growth (YoY) 33.88%
Years of Dividend Growth n/a
Payout Ratio 83.79%
Buyback Yield 0.07%
Shareholder Yield 2.68%
Earnings Yield 3.10%
FCF Yield 3.46%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6